Target intelligence / Profile preview

Physiological bile secretion machinery

Molecular classification
Transporter, Receptor, Enzyme, Ion channel
01

Overview

The physiological bile secretion machinery is a complex, integrated system of transporters, enzymes, and regulatory proteins located primarily in hepatocytes and cholangiocytes. It is responsible for the synthesis, transport, and secretion of bile, which is essential for the digestion and absorption of dietary fats and the elimination of endogenous waste products and xenobiotics. Key components include canalicular transporters like the Bile Salt Export Pump (ABCB11) and Multidrug Resistance-associated Protein 2 (ABCC2), as well as basolateral uptake transporters like the Sodium-taurocholate Cotransporting Polypeptide (SLC10A1). The system is tightly regulated by nuclear receptors, most notably the Farnesoid X Receptor (NR1H4), which maintains bile acid homeostasis by controlling the expression of these transporters. Dysregulation of this machinery leads to cholestatic liver diseases, characterized by impaired bile flow and the accumulation of toxic bile acids, which can cause liver damage and systemic symptoms like pruritus. Pharmacological modulation of specific components, such as Farnesoid X Receptor agonists or Apical Sodium-dependent Bile Acid Transporter inhibitors, is a major therapeutic strategy for treating various hepatobiliary disorders.

Other names
Bile secretory apparatusHepatobiliary transport systemBile acid transport systemBile formation machineryHepatocyte canalicular secretory system
02

Mechanism of action

Farnesoid X receptor agonism, Apical sodium-dependent bile acid transporter inhibition, Bile salt export pump inhibition, Pregnane X receptor activation, Induction of phase II detoxification enzymes

03

Biological functions

Bile secretionLipid digestionDetoxificationCholesterol homeostasisSignal transductionXenobiotic elimination
04

Disease associations

CholestasisGallstonesPrimary Biliary CholangitisPrimary Sclerosing CholangitisProgressive Familial Intrahepatic CholestasisAlagille syndromeLiver cirrhosis
05

Safety considerations

Drug-induced liver injury (DILI)PruritusFat-soluble vitamin deficiencyDiarrheaGallstone formation
06

Interacting drugs

Obeticholic acid

8 more in the full profile.

07

Biomarkers

Serum total bile acidsAlkaline phosphatase (ALP)Gamma-glutamyl transferase (GGT)Conjugated bilirubin7α-hydroxy-4-cholesten-3-one (C4)Fibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Physiological bile secretion machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological bile secretion machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call